E Fund Management Co., Ltd. Amgen Inc Transaction History

E Fund Management Co., Ltd.

$1.6 Billion
Q1 2024

A detailed history of E Fund Management Co., Ltd. transactions in Amgen Inc stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 7,532 shares of AMGN stock, worth $2.34 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

7,532

Previous 7,651 1.56%

Holding current value

$2.34 Million

Previous $2.2 Million 2.81%

% of portfolio

0.13%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $31,995 - $38,622	-119 Reduced 1.56%	7,532 $2.14 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $85,403 - $96,345	-334 Reduced 4.18%	7,651 $2.2 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $129,659 - $160,975	593 Added 8.02%	7,985 $2.15 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $101,992 - $120,604	-476 Reduced 6.05%	7,392 $1.64 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $29,578 - $36,051	-131 Reduced 1.64%	7,868 $1.9 Million

Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $203,149 - $258,125	-887 Reduced 9.98%	7,999 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $109,087 - $123,030	486 Added 5.79%	8,886 $2 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $81,209 - $90,372	352 Added 4.37%	8,400 $2.04 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $18,199 - $20,133	83 Added 1.04%	8,048 $1.95 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $3,778 - $4,324	19 Added 0.24%	7,965 $1.79 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $17,193 - $20,144	81 Added 1.03%	7,946 $1.69 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $1.75 Million - $2.03 Million	7,865 New	7,865 $1.96 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Amgen Inc Transaction History